Literature DB >> 31177386

FOXP3 immunoregulatory gene variants are independent predictors of human papillomavirus infection and cervical cancer precursor lesions.

Fernando Cezar-Dos-Santos1, Rodolfo Sanches Ferreira1, Nádia Calvo Martins Okuyama1, Kleber Paiva Trugilo1, Michelle Mota Sena1, Érica Romão Pereira1, Ana Paula Lombardi Pereira1, Maria Angelica Ehara Watanabe2, Karen Brajão de Oliveira3.   

Abstract

PURPOSE: FOXP3 is a marker of the T regulatory (Treg) cell subset and drives its function and homeostasis. Its expression maintains the host immunosuppressive state that favors persistence of human papillomavirus (HPV) infection and squamous intraepithelial lesion (SIL) appearance. The present study evaluated the effects of the rs3761548 and rs2232365 intronic single-nucleotide variants (SNVs) and their haplotypes on HPV infection and SIL diagnosis in HPV-infected and -uninfected women.
METHODS: HPV DNA-based detection in cervical specimens was performed by PCR. FOXP3 variants were genotyped by PCR-restriction fragment length polymorphism and haplotype recombination sites were inferred for 208 HPV-infected and 218 HPV-uninfected women diagnosed or not with low- or high-grade intraepithelial lesions of cervix. Case-control analyses were carried out by logistic regression adjusted for several socio-demographic, sexual lifestyle, and clinical data.
RESULTS: The homozygous genotype of the rs3761548 variants (A/A) (related to decreased FOXP3 expression) may exert a protective role against HPV infection in women (ORAj: 0.60; 95% CI 0.36-0.99; p = 0.049) and was an independent predictor of protection against HSIL development (ORAdj: 0.28; 95% CI 0.11-0.68; p = 0.006). In addition, the homozygous genotype (G/G) of the rs2232365 variants (related to increased FOXP3 expression) was independently associated with the HPV infection (ORAdj: 2.10; 95% CI 1.06-4.15; p = 0.033). Haplotype analysis revealed no significant associations in our study.
CONCLUSIONS: Our results reveal the significant and independent associations between FOXP3 genetic variants and susceptibility to HPV infection and SIL diagnosis and their role as biomarkers of HPV infection and cervical lesion management.

Entities:  

Keywords:  FOXP3; Genetic variants; Haplotypes; Human papillomavirus; Squamous intraepithelial lesion

Mesh:

Substances:

Year:  2019        PMID: 31177386     DOI: 10.1007/s00432-019-02951-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  46 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Accounting for decay of linkage disequilibrium in haplotype inference and missing-data imputation.

Authors:  Matthew Stephens; Paul Scheet
Journal:  Am J Hum Genet       Date:  2005-01-31       Impact factor: 11.025

3.  Full HPV typing by a single restriction enzyme.

Authors:  Enrique Santiago; Lucía Camacho; Maria Luisa Junquera; Fernando Vázquez
Journal:  J Clin Virol       Date:  2006-07-24       Impact factor: 3.168

4.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

5.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 6.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

7.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

Review 8.  Cervical cancer.

Authors:  Steven E Waggoner
Journal:  Lancet       Date:  2003-06-28       Impact factor: 79.321

Review 9.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Authors:  Xavier Castellsagué; Nubia Muñoz
Journal:  J Natl Cancer Inst Monogr       Date:  2003

10.  FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene.

Authors:  Tao Zuo; Lizhong Wang; Carl Morrison; Xing Chang; Huiming Zhang; Weiquan Li; Yan Liu; Yin Wang; Xingluo Liu; Michael W Y Chan; Jin-Qing Liu; Richard Love; Chang-Gong Liu; Virginia Godfrey; Rulong Shen; Tim H-M Huang; Tianyu Yang; Bae Keun Park; Cun-Yu Wang; Pan Zheng; Yang Liu
Journal:  Cell       Date:  2007-06-14       Impact factor: 41.582

View more
  4 in total

1.  Integration of scRNA-Seq and TCGA RNA-Seq to Analyze the Heterogeneity of HPV+ and HPV- Cervical Cancer Immune Cells and Establish Molecular Risk Models.

Authors:  Erdong Wei; Amin Reisinger; Jiahua Li; Lars E French; Benjamin Clanner-Engelshofen; Markus Reinholz
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

2.  Genetic association study of intron variants in the forkhead box protein P3 gene in Chinese patients diagnosed with cervical cancer.

Authors:  Feng Shi; Xiao-Xia Pang; Guang-Jing Li; Zhi-Hong Chen; Ming-You Dong; Jun-Li Wang
Journal:  J Cell Mol Med       Date:  2022-03-24       Impact factor: 5.295

3.  Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.

Authors:  Hua-Ju Yang; Jin-Min Xue; Jie Li; Ling-Hong Wan; Yu-Xi Zhu
Journal:  Mol Genet Genomic Med       Date:  2020-03-17       Impact factor: 2.183

4.  Sex and FOXP3 gene rs2232365 polymorphism may be associated with the clinical and pathological aspects of chronic viral diseases.

Authors:  Leonn Mendes Soares Pereira; Max Willy da Silva Madureira; Renata Bezerra Hermes de Castro; Isabella Nogueira Abreu; Simone Regina Souza da Silva Conde; Sâmia Demachki; Maisa Silva de Sousa; Maria Alice Freitas Queiroz; Andrea Nazaré M Rangel da Silva; Sandra Souza Lima; Marluísa de Oliveira Guimarães Ishak; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  BMC Immunol       Date:  2020-11-19       Impact factor: 3.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.